-
Weiss Ratings Reaffirms Sell (D-) Rating for 4D Molecular Therapeutics (NASDAQ:FDMT)
Source: Buzz FX / 04 Feb 2025 02:46:09 America/New_York
Weiss Ratings Reaffirms Sell (D-) Rating for 4D Molecular Therapeutics (NASDAQ:FDMT) Written by MarketBeat February 4, 2025 Share Link copied to clipboard. 4D Molecular Therapeutics ( NASDAQ:FDMT - Get Free Report ) 's stock had its "sell (
Read more...